Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Mech Behav Biomed Mater ; 18: 100-7, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23262308

RESUMO

Elevated red blood cell (RBC) aggregation increases low-shear blood viscosity and is closely related to several pathophysiological diseases such as atherosclerosis, thrombosis, diabetes, hypertension, cancer, and hereditary chronic hemolytic conditions. Non-ionic linear polymers such as poly(ethylene glycol) (PEG) and Pluronic F68 have shown inhibitory effects against RBC aggregation. However, hypersensitivity reactions in some individuals, attributed to a diblock component of Pluronic F68, have been reported. Therefore, we investigated the use of an amphiphilic star-shaped PEG polymer based on a cholic acid core as a substitute for Pluronics to reduce RBC aggregation. Cholic acid is a natural bile acid produced in the human liver and therefore should assure biocompatibility. Cholic acid based PEG polymers, termed CA(PEG)(4), were synthesized by anionic polymerization. Size exclusion chromatography indicated narrow mass distributions and hydrodynamic radii less than 2 nm were calculated. The effects of CA(PEG)(4) on human RBC aggregation and blood viscosity were investigated and compared to linear PEGs by light transmission aggregometry. Results showed optimal reduction of RBC aggregation for molar masses between 10 and 16 kDa of star-shaped CA(PEG)(4) polymers. Cholic acid based PEG polymers affect the rheology of erythrocytes and may find applications as alternatives to linear PEG or Pluronics to improve blood fluidity.


Assuntos
Ácido Cólico/química , Agregação Eritrocítica/efeitos dos fármacos , Interações Hidrofóbicas e Hidrofílicas , Polietilenoglicóis/química , Polietilenoglicóis/farmacologia , Humanos , Polietilenoglicóis/síntese química , Reologia , Relação Estrutura-Atividade
2.
Carbohydr Res ; 342(11): 1525-9, 2007 Aug 13.
Artigo em Inglês | MEDLINE | ID: mdl-17509547

RESUMO

Starch is subjected to chemical treatments such as cross-linking or hydroxypropylation to meet the material requirements for food uses or controlled release in the pharmaceutical industries. In this work, two types of cross-linking formulations have been employed for the preparation of high amylose starch for use as an excipient for sustained drug release. The structural differences and chain dynamics of the modified starches in the dry and hydrated states have been compared by the use of variable contact time cross polarization-magic angle spinning solid state (13)C NMR spectroscopy.


Assuntos
Amilose/química , Espectroscopia de Ressonância Magnética , Água/química , Isótopos de Carbono , Reagentes de Ligações Cruzadas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...